News | Womens Healthcare | August 20, 2015

WomenHeart Hosting First National Policy & Science Summit on Women's Cardiovascular Health

Leaders in women’s cardiovascular disease, patient advocacy and others will work to identify policy steps through solutions to scientific questions

WomenHeart, National Policy & Science Summit on Women's Cardiovascular Health, cardiovascular disease, summit, commentary

August 20, 2015 — WomenHeart: The National Coalition for Women with Heart Disease announced that it will host the first National Policy & Science Summit on Women's Cardiovascular Health, Oct. 26-27, 2015 in Washington, D.C. The event is presented in a commentary, Taking a Giant Step Toward Women's Heart Health: Finding Policy Solutions to Unanswered Research Questions, which is a history of the 30-year women's heart health movement. The commentary is published in the September/October issue of Women's Health Issues, the official journal of the Jacobs Institute of Women's Health at the Milken Institute School of Public Health at The George Washington University.

Based on the historical overview in the commentary, the National Policy & Science Summit on Women's Cardiovascular Health is a significant and timely next step in the national effort to eradicate heart disease as the leading cause of death in women.

"The Summit is a game changer for the field of women's cardiovascular health," said Mary E. McGowan, CEO of WomenHeart. "Leaders in this field and patients are meeting to address the lack of sufficient policy, programs and funding for a disease that continues to debilitate and kill more women than all cancers combined. The Summit committee and participants are dedicated to making policy and scientific recommendations that will end the disparities in early and accurate diagnosis and proper treatment for women with heart disease," she continued.

Heart disease is the leading cause of death in women, and more women than men have died from cardiovascular disease each year since 1984. In the commentary, the authors provide the 30-year history of the women's heart health movement, which highlights the fact that while women's cardiovascular disease has been on the medical landscape for nearly 30 years, it was not until this century that significant federal funding was allocated to build awareness and promote prevention. However, due to the underrepresentation of women in clinical trials and insufficient funding for women-specific research regarding medications, medical devices, and procedures for women with heart disease, progress in diagnosis and treatment has been slow.

"Our past efforts described in the commentary have shown the progress we have made, but we clearly have further to go - both in research needs and policy changes to promote women's heart health," said co-author Susan F. Wood, Ph.D., associate professor, Department of Health Policy and Management, director, Jacobs Institute of Women's Health, The George Washington University, Milken Institute School of Public Health.

"Despite many advances, heart disease remains the number one cause of death in women," said commentary authors. "There continues to be a lack of specific attention on sex and gender differences in research, prevention, diagnosis and treatment in both our public health strategies and healthcare systems. Change is clearly needed in our approach to addressing these high priorities if we are to effectively reduce the burden of heart disease in women," they said.

The Summit will bring together leaders in the field of women's cardiovascular disease, patient advocates and others who will critically evaluate the state of women's heart health. The goal is to identify policy steps needed to ensure the establishment of a woman-centered approach to heart health through the development of solutions to the scientific questions posed for Summit participants.

Participation in the National Policy & Science Summit on Women's Cardiovascular Health is by invitation only.

For more information:

Related Content

ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging| August 18, 2017
August 18, 2017 — The American Society of...
Review Paper Calls for Gender-Specific Heart Health Strategies
News | Womens Healthcare| August 08, 2017
August 8, 2017 — Radical changes to our healthcare system accounting for the unique needs of...
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG| August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
New Study Focuses on Protein Responsible For Increased Heart Disease Risk
News | Cardiac Diagnostics| August 03, 2017
August 3, 2017 — A study to reduce the strongest inherited...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Philips released a new version of its iFR system that displays FFR readings as an overlay on live angiographic, angiogram images.

Philips released a new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions. The system is supposed to speed diagnostic decision making and help guide percutaneous revascularization procedures. 

Feature | FFR Catheters| July 31, 2017 | Dave Fornell
The gold standard for assessing the hemodynamic significance of coronary lesions to determine if they should be revas
Siemens Healthineers to Acquire Epocal from Alere
News | Point of Care Testing| July 26, 2017
Siemens Healthineers has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of Alere Inc. Epocal...
New PET-CT Scan Improves Detection in Rare Cardiac Condition
News | PET-CT| July 25, 2017
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests,...
3-D Vascular Ultrasound Quantifies Plaque Burden to Estimate Cardiovascular Risk
News | Cardiovascular Ultrasound| July 20, 2017
July 20, 2017 — In a large, first-of-its-kind population, researchers found an experimental technique known as...
Overlay Init